5184
Y. Wang et al. / Tetrahedron Letters 48 (2007) 5181–5184
4. (a) Flynn, D. L.; Devraj, R. V.; Naing, W.; Parlow, J. J.;
References and notes
Weidner, J. J.; Yang, S. Med. Chem. Res. 1998, 8, 219–243;
(b) Weidner, J. J.; Parlow, J. J.; Flynn, D. L. Tetrahedron
Lett. 1999, 40, 239–242; (c) Ian, P.; Berta, D.; Porco, J. A.;
South, M. S.; Parlow, J. J. J. Org. Chem. 2003, 68, 9678–
9686; (d) Wang, Y.; Sauer, D. Org. Lett. 2004, 6, 2793–2796.
1. (a) Chambers, M. S.; Hobbs, S. C.; Graham, M. I.; Watt,
A. P.; Fletcher, S. R.; Baker, R.; Freedman, S. B.; Patel, S.;
Smith, A. J.; Matassa, V. G. Bioorg. Med. Chem. Lett.
1995, 5, 2303–2308; (b) Johnson, D. C., II; Widlanski, T. S.
Tetrahedron Lett. 2001, 42, 3677–3679; (c) Lobb, K. L.;
Hipskind, P. A.; Aikins, J. A.; Alvarez, E.; Cheung, Y.-Y.;
Considine, E. L.; De Dios, A.; Durst, G. L.; Ferritto, R.;
Grossman, C. S.; Giera, D. D.; Hollister, B. A.; Huang, Z.;
Iversen, P. W.; Law, K. L.; Li, T.; Lin, H.-S.; Lopez, B.;
Lopez, J. E.; Martin Cabrejas, L. M.; MaCann, D. J.;
Molero, V.; Reilly, J. E.; Richett, M. E.; Shih, C.; Teicher,
B.; Wikel, J. H.; White, W. T.; Mader, M. M. J. Med.
Chem. 2004, 47, 5367–5380; (d) Yuan, H.; Silverman, R. B.
Bioorg. Med. Chem. 2006, 14, 1331–1338; (e) Mader, M.
M.; Shih, C.; Considine, E.; De Dios, A.; Grossman, C. S.;
Hipskind, P. A.; Lin, H.-S.; Lobb, K. L.; Lopez, B.; Lopez,
J. E.; Cabrejas, L. M. M.; Richett, M. E.; White, W. T.;
Cheung, Y.-Y.; Huang, Z.; Reilly, J. E.; Dinn, S. R. Bioorg.
Med. Chem. Lett. 2005, 15, 617–620.
2. (a) Sauer, D. R.; Kalvin, D.; Phelan, K. M. Org. Lett. 2003,
5, 4721–4724; (b) Wang, Y.; Miller, R. L.; Sauer, D. R.;
Djuric, S. W. Org. Lett. 2005, 7, 925–928; (c) Wang, Y.;
Sauer, D. R.; Djuric, S. W. Tetrahedron Lett. 2006, 47, 105–
108; (d) Wang, Y.; Sarris, K.; Sauer, D. R.; Djuric, S. W.
Tetrahedron Lett. 2006, 47, 4823–4826; (e) Wang, Y.; Sarris,
K.; Sauer, D. R.; Djuric, S. W. Tetrahedron Lett. 2007, 48,
2237–2240.
6. The desired amount of DMAP was dissolved in 1 ml of
CH2Cl2 and transferred via pipet to a pre-packed cartridge
of Si-SCX (1 g, 0.8 mmol/g). The filtrate was collected via
gravity filtration. The cartridge was washed with additional
amounts of CH2Cl2 (MeOH for Table 2, entry 3). The
filtrate was analyzed by LC/MS. No peak was detected for
Table 2, entries 1–4. When 0.8 mmol DMAP was used
(Table 2, entry 5), the filtrate was dried down and weighed,
15% of DMAP was recovered after the flow-through.
7. General procedure: To a 20 ml scintillation vial was added
0.3 mmol of PS-DCC (1.5 equiv, 1.2 mmol/g) followed by
0.2 mmol acid and 0.2 mmol sulfonamide in 2 ml of
CH2Cl2. DMAP (0.2 mmol) is added to the above solution
and the reaction mixture was shaken at room temperature
on a J-Chem heater/shaker. The reaction was checked
periodically by LC/MS. In most cases, the reaction was
completed within 1 h. The reaction mixture was directly
transferred via a pipet to a pre-packed cartridge of 1 g
Si-SCX (0.8 mmol loading) via gravity filtration. The cartridge
was washed with additional amounts of CH2Cl2 until no
peak was detected in the fractions collected. The filtrate was
combined and dried down. In all cases but one (Table 3,
entry 9), the products thus collected have greater than 97%
purity as determined by NMR and LC/MS without the
need for any further purification. Products from entry 9 was
purified by reverse-phase HPLC. When there is basic
functionality in the product (entry 14), the crude material
was purified by reverse-phase HPLC without filtering
through a Si-SCX cartridge.
3. (a) Drummond, J. T.; Johnson, G. Tetrahedron Lett. 1988,
29, 1653–1656; (b) Desai, M. C.; Stramiello, L. S. Tetra-
hedron Lett. 1993, 34, 7685–7688; (c) Pelletier, J. C.;
Hesson, D. P. Synlett 1995, 1141–1142; (d) Sturino, C. F.;
Labelle, M. Tetrahedron Lett. 1998, 39, 5891–5894; (e)
Ishizuka, N.; Matsumura, K.; Hayashi, K.; Sakai, K.;
Yamamori, T. Synthesis 2000, 6, 784–788.